144 results
Page 3 of 8
8-K
odq 1lu4dz6d9yt69v
6 Nov 20
Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
9:05am
424B5
ps19algsicg49i mgrz
18 Sep 20
Prospectus supplement for primary offering
5:19pm
424B5
fn32w1u04t a7r
15 Sep 20
Prospectus supplement for primary offering
7:15am
424B3
abaz52qizzx
17 Aug 20
Prospectus supplement
8:45am
DEF 14C
3vxkc7dpxr4i99xvp83b
14 Aug 20
Information statement
4:41pm
424B3
lvjzxin3ew1
5 Aug 20
Prospectus supplement
5:06pm
PRE 14C
mb3zky0am
3 Aug 20
Preliminary information
5:02pm
8-K
jx6f5a 2r1kfd45
16 Jun 20
Regulation FD Disclosure
4:30pm
POS AM
kqmfl7xcb8 dzh2p9qv0
23 Mar 20
Prospectus update (post-effective amendment)
5:24pm
424B3
j7zko 2nz
4 Dec 19
Prospectus supplement
4:49pm
D
f9fj38364e8
22 Nov 19
$20.49M in equity, sold $494.61K, 1 investor
4:35pm
8-K
EX-10.1
xjzck8cb3sn tl
12 Nov 19
Entry into a Material Definitive Agreement
5:28pm